一个患者组织的观点:为SCN2A相关疾病治愈的过程绘制路线
Leah F Schust1, Jennifer Burke1, Christina SanInocencio1
1FamilieSCN2A Foundation 501(c)(3), Gettysburg, PA, USA.
Therapeutic advances in rare disease
|November 13, 2024
概括
家庭SCN2A基金会为SCN2A相关疾病的研究提供资金,旨在寻找治疗方法. 他们的战略计划建立了基础设施,以推进药物开发,并增加SCN2A基因突变患者成功治疗的可能性.
科学领域:
- 遗传学和神经学 遗传学和神经学
- 分子生物学分子生物学
- 患者倡导 患者倡导
背景情况:
- 该SCN2A基因编码Nav1.2蛋白,这是神经元中的一个关键的电压门通道.
- SCN2A中的突变会导致严重的神经发育障碍,包括,自闭症和智力障碍.
- 与SCN2A相关的疾病显著影响患者的生活质量,需要紧急的治疗干预.
研究的目的:
- 概述家族SCN2A基金会的战略计划和举措.
- 详细介绍基金会为SCN2A相关疾病建立研究基础设施的努力.
- 要突出基金会加速治疗疗法的发展的目标.
主要方法:
- 建立一个全面的研究准备基础设施.
- 资助研究资助,以促进SCN2A疾病的理解和治疗.
- 在SCN2A研究和患者社区建立战略伙伴关系.
主要成果:
- 筹集了大约600万美元用于支持SCN2A研究.
- 资助了26项总额约为470万美元的研究资助.
- 开发了致力于SCN2A研究的利益相关者强大的生态系统.
结论:
- 家庭SCN2A基金会的战略方法正在积极加速治疗和治愈的进展.
- 在SCN2A研究和协作生态系统的重大进展表明患者的前景是积极的.
- 该基金会的模型最大限度地提高了为罕见遗传疾病开发药物的成功概率.
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K